MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Marker Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.20+0.16 (+15.38%)
Close on Oct 19, 2026
- Market cap
- $23.18M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 22, 2023(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jan 27, 2023 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Sep 16, 2016 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Sep 16, 2016 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Feb 25, 2014 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Jul 27, 2009 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jun 28, 2007 | 1-for-2.5 reverse | Earlier per-share figures multiplied by 2.5 |